The antihypertensive drug carvedilol inhibits the activity of mitochondrial NADH-ubiquinone oxidoreductase
- PMID: 12392188
- DOI: 10.1023/a:1020248300766
The antihypertensive drug carvedilol inhibits the activity of mitochondrial NADH-ubiquinone oxidoreductase
Abstract
A study is presented on the interaction of carvedilol with mitochondria isolated from several rat organs. It is shown that carvedilol causes a moderate uncoupling effect under non phosphorylating succinate supported respiration of intact mitochondria, as well as a marked inhibition of coupled respiration with NAD-dependent substrates. The inhibitory effect was also found in the bovine heart purified Complex I as well as in experiments with mitochondrial particles, where the individual redox segments of the respiratory chain were analysed. It is also shown that carvedilol, though exhibiting an intrinsic scavenger activity, caused reactive oxygen species to be produced as a consequence of its inhibitory effect on the steady-state respiration. Under these conditions the pro-oxidant activity of carvedilol appears to prevail over its scavenging activity, and a net generation of ROS is promoted.
Similar articles
-
Carvedilol inhibits the exogenous NADH dehydrogenase in rat heart mitochondria.Arch Biochem Biophys. 2000 Feb 15;374(2):279-85. doi: 10.1006/abbi.1999.1624. Arch Biochem Biophys. 2000. PMID: 10666308
-
Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy.Toxicol Appl Pharmacol. 2002 Dec 15;185(3):218-27. doi: 10.1006/taap.2002.9532. Toxicol Appl Pharmacol. 2002. PMID: 12498738
-
Pro- and anti-oxidant activities of the mitochondrial respiratory chain: factors influencing NAD(P)H-induced lipid peroxidation.Biochim Biophys Acta. 1997 Jan 16;1318(1-2):246-54. doi: 10.1016/s0005-2728(96)00142-9. Biochim Biophys Acta. 1997. PMID: 9030267
-
Generation of superoxide by the mitochondrial Complex I.Biochim Biophys Acta. 2006 May-Jun;1757(5-6):553-61. doi: 10.1016/j.bbabio.2006.03.013. Epub 2006 Apr 17. Biochim Biophys Acta. 2006. PMID: 16678117 Review.
-
Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection.Eur Heart J. 1996 Apr;17 Suppl B:24-9. doi: 10.1093/eurheartj/17.suppl_b.24. Eur Heart J. 1996. PMID: 8733068 Review.
Cited by
-
Beta-Blockers of Different Generations: Features of Influence on the Disturbances of Myocardial Energy Metabolism in Doxorubicin-Induced Chronic Heart Failure in Rats.Biomedicines. 2024 Aug 28;12(9):1957. doi: 10.3390/biomedicines12091957. Biomedicines. 2024. PMID: 39335471 Free PMC article.
-
Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy.Circ Res. 2020 Mar 27;126(7):926-941. doi: 10.1161/CIRCRESAHA.119.314681. Epub 2020 Mar 26. Circ Res. 2020. PMID: 32213135 Free PMC article. Review.
-
Drug-induced mitochondrial toxicity: Risks of developing glucose handling impairments.Front Endocrinol (Lausanne). 2023 Feb 13;14:1123928. doi: 10.3389/fendo.2023.1123928. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36860368 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical